MicroRNA‐335‐5p and ‐3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance

No abstract is available for this paper.

• Publication year

  2017

• Venue

  FEBS Letters

• Publication date

  2017-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1873-3468.12538PMID 28008602PMCID PMC5853108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer

  2015cited by this paper
• The UCSC Cancer Genomics Browser: update 2015

  2014cited by this paper
• Preferential star strand biogenesis of pre‐miR‐24‐2 targets PKC‐alpha and suppresses cell survival in MCF‐7 breast cancer cells

  2014cited by this paper
• Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer

  2013cited by this paper
• Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review)

  2013cited by this paper
• A new method for stranded whole transcriptome RNA-seq.

  2013cited by this paper
• The UCSC Cancer Genomics Browser: update 2013

  2012cited by this paper
• MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

  2011cited by this paper
• MicroRNA miR‐335 is crucial for the BRCA1 regulatory cascade in breast cancer development

  2011cited by this paper
• Cracking the estrogen receptor's posttranslational code in breast tumors.

  2011cited by this paper
• A positive cross-regulation of HER2 and ER-α36 controls ALDH1 positive breast cancer cells.

  2011cited by this paper
• Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM

  2010cited by this paper
• The UCSC cancer genomics browser: update 2011

  2010cited by this paper
• Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation.

  2010cited by this paper
• Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells.

  2010cited by this paper
• miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells

  2010cited by this paper
• MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.

  2010cited by this paper
• Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

  2010cited by this paper
• ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

  2010cited by this paper
• Many roads to maturity: microRNA biogenesis pathways and their regulation

  2009cited by this paper
• edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

  2009cited by this paper
• Estrogen receptor‐alpha (ER‐α) suppresses expression of its variant ER‐α36

  2009cited by this paper
• MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦

  2008cited by this paper
• MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer*

  2008cited by this paper
• Small-sample estimation of negative binomial dispersion, with applications to SAGE data.

  2007cited by this paper
• Moderated statistical tests for assessing differences in tag abundance

  2007cited by this paper
• Growth factor signalling in endocrine and anti-growth factor resistant breast cancer

  2007cited by this paper
• The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.

  2007cited by this paper
• The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-α (ERα) and Represses ERα Messenger RNA and Protein Expression in Breast Cancer Cell Lines

  2007cited by this paper
• Expression of active Akt protects against tamoxifen‐induced apoptosis in MCF‐7 Cells

  2006cited by this paper
• Antiestrogenic Glyceollins Suppress Human Breast and Ovarian Carcinoma Tumorigenesis

  2006cited by this paper
• Nature Publishing Group

  2006cited by this paper
• Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant.

  2006cited by this paper
• Isoform-Specific Ras Activation and Oncogene Dependence during MYC- and Wnt-Induced Mammary Tumorigenesis

  2006cited by this paper
• ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis

  2005cited by this paper
• Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.

  2005cited by this paper
• Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5

  2005cited by this paper
• Novel Ceramide Analogs as Potential Chemotherapeutic Agents in Breast Cancer

  2004cited by this paper
• Asymmetry in the assembly of the RNAi enzyme complex.

  2003cited by this paper
• Aromatase inhibitors in breast cancer.

  2003cited by this paper
• Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998.

  2003cited by this paper
• Asymmetry in the Assembly of the RNAi Enzyme Complex

  2003cited by this paper
• The Transcriptional Co-activators CBP and p300 Are Activated via Phenylephrine through the p42/p44 MAPK Cascade*

  2002cited by this paper
• Endocrine-responsive breast cancer and strategies for combating resistance

  2002cited by this paper
• Nck-Interacting Ste20 Kinase Couples Eph Receptors to c-Jun N-Terminal Kinase and Integrin Activation

  2000cited by this paper
• Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-κB

  1998cited by this paper
• Activation of MEK‐1 and SEK‐1 by Tpl‐2 proto‐oncoprotein, a novel MAP kinase kinase kinase.

  1996cited by this paper
• Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase

  1995cited by this paper

• Exosome-Mediated Cellular Communication in the Tumor Microenvironment Imparts Drug Resistance in Breast Cancer

  2025cites this paper
• Micro-RNAs targeting the estrogen receptor alpha involved in endocrine therapy resistance in breast cancer.

  2025cites this paper
• miRNA-dependent resistance mechanisms to anti-hormonal therapies in estrogen receptor-positive breast cancer patients

  2025cites this paper
• Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance

  2025cites this paper
• The Role of Heavy Metals in the Biology of Female Cancers

  2025cites this paper
• Cellular and Exosomal MicroRNAs: Emerging Clinical Relevance as Targets for Breast Cancer Diagnosis and Prognosis

  2024cites this paper
• Non-coding RNAs and estrogen receptor signaling in breast cancer: Nanotechnology-based therapeutic approaches.

  2024cites this paper
• Transcription factors and hormone receptors: Sex‑specific targets for cancer therapy (Review)

  2024cites this paper
• miR-205 Regulates Tamoxifen Resistance by Targeting Estrogen Receptor Coactivator MED1 in Human Breast Cancer

  2024cites this paper
• In silico analysis of hippo signaling pathway associated microRNAs in breast cancer

  2024cites this paper
• The Impact of miRNAs on the Efficacy of Tamoxifen in Breast Cancer Treatment: A Systematic Review.

  2024cites this paper
• Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer

  2023cites this paper
• Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies

  2022cites this paper
• Influence of age and sex on microRNA response and recovery in the hippocampus following sepsis

  2022cites this paper
• Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation

  2022cites this paper
• Fractionated irradiation of MCF7 breast cancer cells rewires a gene regulatory circuit towards a treatment‐resistant stemness phenotype

  2022cites this paper
• MicroRNAs as a clue to overcome breast cancer treatment resistance

  2021cites this paper
• Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells.

  2021cites this paper
• MiR-335-3p inhibits cell proliferation, induces cell cycle arrest and apoptosis in acute myeloid leukemia by targeting EIF3E.

  2021cites this paper
• From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells

  2021influential citation
• Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer

  2020cites this paper
• LINC00319 acts as a microRNA-335-5p sponge to accelerate tumor growth and metastasis in gastric cancer by up-regulating ADCY3.

  2020cites this paper
• Upregulation of the Coatomer Protein Complex Subunit beta 2 (COPB2) Gene Targets microRNA-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration

  2020cites this paper
• Up-regulation of microRNA-335-5p reduces inflammation via negative regulation of the TPX2-mediated AKT/GSK3β signaling pathway in a chronic rhinosinusitis mouse model.

  2020cites this paper
• Genetics of blood malignancies among Iranian population: an overview

  2020cites this paper
• Regulation of breast cancer metastasis signaling by miRNAs

  2020cites this paper
• Perspectives on the Role of Non-Coding RNAs in the Regulation of Expression and Function of the Estrogen Receptor

  2020cites this paper
• LncRNA CDKN2B-AS1 contributes to tumorigenesis and chemoresistance in pediatric T-cell acute lymphoblastic leukemia through miR-335-3p/TRAF5 axis.

  2020cites this paper
• miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment

  2020cites this paper
• Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.

  2019cites this paper
• From “Junk DNA” to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAs

  2019cites this paper
• Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers.

  2019cites this paper
• Antifibrotic Potential of MiR-335-3p in Hereditary Gingival Fibromatosis

  2019cites this paper
• MiR-26b-3p regulates osteoblast differentiation via targeting estrogen receptor α.

  2019cites this paper
• Circular RNA TLK1 Aggravates Neuronal Injury and Neurological Deficits after Ischemic Stroke via miR-335-3p/TIPARP

  2019cites this paper
• The role of exosomal microRNAs; focus on clinical applications in breast cancer

  2019cites this paper
• Evaluation and Detection of Exosomes and Exosomal microRNAs in Breast Cancer

  2019cites this paper
• MicroRNA-335/ID4 dysregulation predicts clinical outcome and facilitates leukemogenesis by activating PI3K/Akt signaling pathway in acute myeloid leukemia

  2019cites this paper
• MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer

  2019cites this paper
• MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.

  2019cites this paper
• Mirna biogenesis pathway is differentially regulated during adipose derived stromal/stem cell differentiation

  2018cites this paper
• Estrogen Receptor Regulation of MicroRNAs in Breast Cancer

  2018cites this paper
• Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

  2018cites this paper
• microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy

  2018cites this paper
• The Network of Non-coding RNAs in Cancer Drug Resistance

  2018cites this paper
• Expression profile of circular RNAs in IDH-wild type glioblastoma tissues.

  2018cites this paper
• miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma

  2018cites this paper
• Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy

  2018cites this paper